The University of Szeged (SZTE) and the Hungarian subsidiary of Eli Lilly have signed a five-year cooperation agreement to support the development of Hungarian healthcare, medical education, research and public health. The partnership will combine the university’s academic and clinical expertise with Lilly’s global experience in pharmaceutical innovation, with the aim of improving patient care and contributing to healthcare development in Hungary.
The partnership draws on the research expertise and knowledge accumulated at the University of Szeged and Eli Lilly’s 150 years of experience in pharmaceuticals and innovation. Their cooperation will focus on three major areas of public health: cardiometabolic, oncological and neurological diseases.
The partners will develop scientifically sound, accessible information to help translate research findings and medical knowledge into practice, covering areas from early detection and prevention to more effective patient care.
The agreement was signed on 17 November 2026, during SZTE Innovation Day, by Prof. Dr. Zoltán Kónya, Vice-Rector for Science and Innovation at the University of Szeged and Head of the Interdisciplinary Research and Development and Innovation Excellence Center, and Hera Cuku, Managing Director of Lilly Hungária Kft.
The cooperation will also focus on improving health literacy and making current medical knowledge more widely accessible. Through joint programmes and professional initiatives, the two organisations aim to support patients, healthcare professionals and the wider public.
The partnership will facilitate the exchange of knowledge between research and everyday healthcare practice. It will help healthcare professionals access the latest medical findings and developments in patient care, while promoting prevention and informed health decisions among the public.
The partners will also explore how real-world data generated through routine patient care can be used in scientific research.
“Pharmaceutical innovation has its greatest impact when it makes a difference in patients’ lives. This requires partners with different areas of expertise who can work towards shared goals. Our agreement with the University of Szeged provides an opportunity to combine university and clinical knowledge, research experience and Lilly’s international innovation expertise. Lilly has been present in Hungary for 35 years, and throughout this time we have worked to ensure that the latest scientific advances translate into tangible benefits for Hungarian patients,” said Hera Cuku, Managing Director of Lilly Hungária Kft.
“The University of Szeged has long maintained close professional relationships with key players in industry, healthcare and research. These partnerships help translate the knowledge and research developed at the university into practical applications that benefit society. The five-year agreement with the Hungarian subsidiary of Eli Lilly further strengthens this network and creates opportunities for cooperation in innovation, education and research,” said Prof. Dr. Zoltán Kónya, Vice-Rector for Science and Innovation at the University of Szeged and Head of the Interdisciplinary Research and Development and Innovation Excellence Center.
Photo: Dávid Miskolci






